Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;37(1):639-643.
doi: 10.1007/s10103-021-03315-z. Epub 2021 Apr 14.

Evaluation of a novel deep tissue transvaginal near-infrared laser and applicator in an ovine model

Affiliations

Evaluation of a novel deep tissue transvaginal near-infrared laser and applicator in an ovine model

Ralph Zipper et al. Lasers Med Sci. 2022 Feb.

Abstract

Photobiomodulation therapy (PBMT) is an effective means of treating muscle spasm and pain. A novel near-infrared laser system has been commercialized for the treatment of myofascial pelvic pain in women (SoLá Therapy, UroShape, LLC). This study was undertaken to determine if this device is capable of delivering therapeutic levels of irradiance to the pelvic muscles and to identify the surface irradiance required to achieve this goal. This novel class IV near-infrared laser and transvaginal applicator were used to deliver near-infrared light energy through the vaginal mucosa of an adult Suffolk/Dorset Ewe. Irradiance was measured on the surface of the levator ani muscle, inside the levator ani muscle, and inside the bladder. Measurements were taken at powers of 5 W and 0.5 W. 3.0% of vaginal surface irradiance was measured inside of the levator ani muscle. 4.4% of vaginal surface irradiance was measured inside the bladder. At 5 W, the novel laser system provided a surface irradiance of 738 mW/cm2. At 0.5 W, the system provided a surface irradiance of 74 mW/cm2. A novel class IV near-infrared laser and transvaginal applicator delivered therapeutic irradiance to the levator ani muscle and bladder of an anesthetized ewe at a power setting of 5 W. A power setting of 0.5 W failed to deliver therapeutic energy into either the levator ani muscle or bladder. Clinical applications targeting deeper tissues such as the pelvic muscles and or bladder should consider power settings that exceed 0.5 W and or irradiance of ≥ 75 mW/cm2.

Keywords: Irradiance; Pain; Pelvis; Photobiomodulation; Therapy.

PubMed Disclaimer

Conflict of interest statement

Ralph Zipper, MD, FPMRS, is the CEO of UroShape, LLC, the manufacturer of the deep tissue transvaginal near-infrared laser and applicator. Dr. Zipper has a financial interest in UroShape, LLC.

Brian Pryor, Ph.D., is the CEO of Litecure, LLC, the supplier of the diode laser used in the manufacture of the UroShape laser system. Dr. Pryor has a financial interest in UroShape, LLC.

Figures

Fig. 1
Fig. 1
The SoLá Pelvic Therapy Laser System and its transvaginal delivery system. The delivery system consists of a reusable handpiece and proprietary laser fiber that radiates energy perpendicular to the fiber. The distal handpiece is covered by a single-use, sterile, wand with a bulbous tip. Inset is the BK 2712 Precision Multimeter with a custom B&W Tek near-infrared Power sensor. These sensors were implanted in the subject

References

    1. Cotler HB, Chow RT, Hamblin MR, Carroll J (2015) The use of low-level laser therapy (LLLT) for musculoskeletal pain. MOJ Orthop Rheumatol 2(5). 10.15406/mojor.2015.02.00068 - PMC - PubMed
    1. Mathias SD, Kuppermann M, Liberman RF, Lipschutz RC, Steege JF. Chronic pelvic pain: prevalence, health-related quality of life, and economic correlates. Obstet Gynecol. 1996;87(3):321–327. doi: 10.1016/0029-7844(95)00458-0. - DOI - PubMed
    1. Cichowski SB, Rogers RG, Komesu Y, Murata E, Qualls C, Murata A, Murata G. A 10-yr analysis of chronic pelvic pain and chronic opioid therapy in the women veteran population. Military Medicine. 2018;183(11-12):e635–e640. doi: 10.1093/milmed/usy114. - DOI - PubMed
    1. Adams K, Gregory WT, Osmundsen B, Clark A. Levator myalgia: why bother? Int Urogynecol J. 2013;24(10):1687–1693. doi: 10.1007/s00192-013-2089-8. - DOI - PubMed
    1. Meister MR, Sutcliffe S, Badu A, Ghetti C, Lowder JL. Pelvic floor myofascial pain severity and pelvic floor disorder symptom bother: is there a correlation? Am J Obstet Gynecol. 2019;221(3):235 e231-235 e215. doi: 10.1016/j.ajog.2019.07.020. - DOI - PMC - PubMed

Grants and funding